Molecular diagnostics are well-established in clinical medicine. Nonetheless, the markets for these tests remain one of the most attractive growth opportunities in the in vitro diagnostics industry.

Antimicrobial resistance (AMR) remains a major global healthcare challenge, undermining the effectiveness of treatments for common infections and threatening modern medical advances. Improved ...

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

Cytespace Africa Laboratories (Cytespace), an MLM Medical Labs company and the only fully CAP-accredited central laboratory in South Africa, has significantly expanded its molecular testing ...

LONDON, Oct. 19, 2017 /PRNewswire/ -- By 2024, United States molecular diagnostics market is expected to cross US$ 9 billion. Main factors pouring the growth of molecular diagnostics market are ...

FRANKLIN LAKES, N.J., May 12, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. launch of its new, fully ...

ARLINGTON, Va., June 17, 2025 /PRNewswire/ -- Kalorama Information, a leading authority in healthcare market intelligence, has released the latest edition of its bimonthly publication, In Vitro ...

Dublin, Dec. 11, 2025 (GLOBE NEWSWIRE) -- The "Clinical Laboratory Molecular Diagnostics for Infectious Disease Markets 2025-2029: Strategies, Trends, and Forecasts by Application, Place and Country ...

DUBLIN, July 23, 2021 /PRNewswire/ -- The "The World Market for Molecular Diagnostics Tests, 10th Edition" report has been added to ResearchAndMarkets.com's offering. Molecular diagnostics is a fast ...

Effective quality control (QC) data management is essential for ensuring reliability of reported patient results and regulatory compliance in molecular infectious disease laboratories. This session ...